Gala Health Review 2026
Reviewed August 7, 2026 · Both — compounded GLP-1 and microdosed GLP-1/GIP (not FDA-approved) plus brand-name Ozempic, with the Wegovy pill listed as coming.
Visit Gala Health WebsiteOverview
Gala Health is a women's telehealth service that puts GLP-1 weight treatment and hormone therapy on the same platform, which is a genuinely sensible piece of design. A large share of the women researching tirzepatide are doing so during perimenopause or menopause, when hormonal change, sleep disruption and body composition shifts all arrive together — and most weight-loss platforms treat only the weight while most menopause platforms treat only the hormones. Gala does both, offering compounded GLP-1 at $179/month with all doses included, a microdosed GLP-1/GIP option at $149/month, brand-name Ozempic at $1,299/month, and an HRT range covering estradiol pill and patch, progesterone, vaginal estradiol and non-hormonal options, organised around midlife symptoms including hot flashes, weight gain, mood, brain fog, sleep and low libido. Providers are licensed in all 50 states, shipping is free, and the all-doses-included pricing removes the escalation trap that catches so many patients elsewhere. Where we would push back is on the evidence presentation. Gala publishes a chart comparing 'GLP-1 + provider care −20%', 'GLP-1 alone −15%', 'Diet + exercise (avg.) −5%' and 'No intervention −1%', attributed to STEP-1. Two problems. The footnote concedes that '*Compounded GLP-1 results model the trial data of the underlying molecule' — meaning these are modelled projections from the branded drug's trial, not results Gala has measured. And the claim that adding provider care lifts the result from 15% to 20% has nothing behind it at all.
Medications Offered
Brand-name or compounded: Both — compounded GLP-1 and microdosed GLP-1/GIP (not FDA-approved) plus brand-name Ozempic, with the Wegovy pill listed as coming.
- Compounded GLP-1 — $179/month, all doses included
- Microdosing GLP-1/GIP — $149/month, positioned for sustained energy, sleep and metabolic balance
- Brand-name Ozempic® — $1,299/month
- Wegovy® pill — listed as coming soon, pricing at launch
- HRT: estradiol pill or patch, progesterone, vaginal estradiol, and non-hormonal options
Consultation Process
60-second assessment
Gala states the assessment takes 60 seconds and covers your body, history and goals, and is used to match you to a medication and flag anything needing closer review.
Licensed provider review
Gala states a US-licensed clinician reads your full profile and prescribes accordingly, or comes back with a question — explicitly 'never a templated form'. Providers are licensed in all 50 states.
Choose compounded, microdosed or branded
Because Gala offers all three, ask whether the brand-name route suits you before accepting compounded — and note the Ozempic price of $1,299/month is approximately full cash list.
Delivery within about a week
Gala describes 'from hello to first dose in a week', with free fast shipping and 24/7 patient support thereafter.
Eligibility
- Women; the service is designed and dosed specifically for women
- Licensed providers in all 50 states
- No published BMI threshold or age range
- No insurance required — the service states 'no insurance hoops'
- Standard GLP-1 contraindications apply; GLP-1s are contraindicated in pregnancy
Provider Involvement
Gala is explicit that a US-licensed clinician reads the full profile rather than applying a template, and that providers are licensed in all 50 states. 24/7 patient support is included. Having HRT prescribing on the same platform means a clinician can consider hormonal drivers alongside weight rather than treating them as separate problems — which for a midlife female population is the right clinical framing. What is not published is any named clinical leadership, monitoring cadence or lab requirement.
Lab Requirements
Not published. This is a gap worth noting given the HRT side of the service, where baseline assessment and periodic review are ordinarily expected. Ask what monitoring applies to whichever treatment you start.
Pharmacy Fulfillment
Not named. Gala offers both compounded and brand-name product; brand-name Ozempic is manufacturer product, while the compounded GLP-1 and microdosed formulations come from an unnamed compounding pharmacy. Ask which facility and its 503A or 503B status.
Shipping Frequency
Free, fast shipping with the whole process from assessment to first dose described as taking about a week.
Membership Fees vs. Medication Fees
Membership fees
None advertised. Pricing is per medication per month with all doses included, and the service states you can cancel anytime.
Medication fees
- Compounded GLP-1: $179/month, all doses included
- Microdosing GLP-1/GIP: $149/month
- Brand-name Ozempic: $1,299/month
- Wegovy pill: pricing at launch
- Shipping: free
Cancellation & Refund Policy
Cancellation
Gala states 'Cancel anytime', which combined with all-doses-included pricing and no membership fee is a clean structure. The specific process and any notice period are not published — confirm before subscribing.
Refunds
Not published on the pages we reviewed.
Insurance
Not used. Gala markets itself on 'no insurance hoops' and prices Ozempic at $1,299/month, which is approximately full cash list. If you have GLP-1 coverage, buying brand-name medication this way would be a significant overpayment — use a provider that bills your pharmacy benefit.
HSA / FSA
Not stated. Confirm directly.
See our GLP-1 insurance and HSA/FSA guide for how reimbursement works in practice.
Support Services
- 24/7 patient support
- Licensed providers in all 50 states
- HRT and GLP-1 treatment on one platform
- Symptom-based guidance across midlife concerns
- Free fast shipping and cancel-anytime terms
State Availability
Gala states it has licensed providers in all 50 states, which is broader and more plainly stated than most compounded competitors manage.
Pros
- Built specifically for women, with GLP-1 and hormone therapy on one platform
- Compounded GLP-1 at $179/month with all doses included — no escalation as you titrate
- Microdosing GLP-1/GIP at $149/month as a lower-intensity option
- Brand-name Ozempic offered alongside compounded, with the Wegovy pill listed as coming
- Licensed providers in all 50 states, stated plainly
- Free fast shipping, cancel anytime and 24/7 patient support
- Discloses that its compounded efficacy figures are modelled rather than measured
Cons
- Presents a modelled efficacy chart as if it showed outcomes, with the caveat in a footnote
- 'GLP-1 + provider care −20%' implies provider care adds five percentage points, with nothing to support it
- Describes STEP-1 as 'twelve-week clinical data' — the trial ran 68 weeks
- Headline statistics render as animated counters, so the actual claimed figures could not be read
- Ozempic at $1,299/month is approximately full cash list
- No named compounding pharmacy, published BMI criteria, lab requirements or refund terms
Who Gala Health May Be Best For
- Women in perimenopause or menopause whose weight change sits alongside hormonal symptoms
- Patients who want hormone therapy and GLP-1 treatment considered together
- People who want all doses at one price with no membership
Limitations
- Modelled efficacy presented as chart data
- Unsupported claim that provider care adds five percentage points
- STEP-1 mischaracterised as twelve-week data
- Brand-name Ozempic priced at cash list
- No named pharmacy, BMI criteria, labs or refund terms
Reputation & Trust
Gala's proposition is well constructed and its evidence presentation is where it slips. The strengths are real: a women-specific service combining GLP-1 treatment with hormone therapy addresses the actual clinical picture for a midlife population better than either type of platform does alone; $179/month with all doses included removes the escalation trap; a $149 microdosing option and brand-name Ozempic give genuine range; providers are licensed in all 50 states; and shipping is free with cancel-anytime terms. It also does something unusual and to its credit — it discloses in a footnote that '*Compounded GLP-1 results model the trial data of the underlying molecule', which is an honest admission that its compounded figures are projections rather than measurements. The problem is that the disclosure sits under a chart that reads as outcome data, showing 'GLP-1 + provider care −20%' against 'GLP-1 alone −15%' and 'Diet + exercise −5%'. The implication that adding provider care produces an extra five percentage points has no support offered. The chart is attributed to 'Twelve-week clinical data from STEP-1', but STEP 1 ran 68 weeks — describing it that way is at best confusing. And the headline statistics render as animated counters that display as zeros in a static fetch, so we could not read the actual claimed figures for patients treated, average reduction or recommendation rate.
What Makes Gala Health Different
- GLP-1 and hormone therapy on one platform, designed for women
- All doses included at $179/month with no escalation
- Microdosing option at $149/month
- Licensed providers in all 50 states
- Discloses that its compounded efficacy figures are modelled
Our Verdict
Gala Health earns 3.5/5. The core idea is genuinely good and under-served: a women's service that prescribes both GLP-1 medication and hormone therapy, so a midlife patient whose weight change arrives alongside hot flashes, disrupted sleep and mood shifts can have all of it considered by the same clinician rather than split across two platforms. The commercial terms support it — $179/month with all doses included so titration does not raise your bill, a $149 microdosing option, brand-name Ozempic available, providers licensed in all 50 states, free shipping and cancel-anytime. Gala also does something we rarely see: it admits in a footnote that its compounded efficacy figures 'model the trial data of the underlying molecule' rather than reflecting its own results. The trouble is that the admission sits beneath a chart presented as outcome data, showing −20% with provider care against −15% for GLP-1 alone, a five-point difference with nothing to support it, attributed to 'twelve-week clinical data from STEP-1' when STEP 1 ran 68 weeks. Its headline counters render as zeros, so the patient numbers and recommendation rates could not be read at all. Good service, well-priced, with a data presentation that needs tightening — and if you have insurance, do not buy the $1,299 Ozempic here.
Alternatives to Gala Health
Menopause care that takes insurance, with live clinician appointments.
Also prescribes both HRT and GLP-1s, from menopause-trained physicians.
Publishes trial data properly, with dose, duration, population and the placebo comparator.
If hormonal symptoms rather than weight are the priority, a dedicated HRT service.
Compare more options on our best online GLP-1 providers and cheapest GLP-1 programs pages.
Frequently Asked Questions
Are Gala's weight-loss figures based on its own patients?
No, and Gala says so in a footnote worth reading: '*Compounded GLP-1 results model the trial data of the underlying molecule.' That means the percentages shown are projections built from the branded drug's clinical trial, not outcomes Gala has measured in its own patients. That disclosure is more honest than most competitors offer — but the chart above it reads like results data, and the '−20% with provider care' figure implies a five-point benefit from provider support that has nothing behind it.
What does Gala cost?
Compounded GLP-1 is $179/month with all doses included, microdosed GLP-1/GIP is $149/month, and brand-name Ozempic is $1,299/month. The all-doses-included part matters — it means titrating to a therapeutic dose does not raise your bill, which is the most common way a cheap GLP-1 programme becomes expensive. Note the Ozempic price is approximately full cash list; if you have coverage, do not buy brand-name medication this way.
Why does a women-specific service matter?
Because the clinical picture often is different. Weight change in midlife frequently sits alongside perimenopausal or menopausal changes — hot flashes, sleep disruption, mood changes and shifts in body composition that hormones drive. Most weight-loss platforms treat only the weight; most menopause platforms treat only the hormones. Gala prescribes both, which means a clinician can weigh whether hormone therapy, GLP-1 treatment or both is the right answer. Whether the medication itself is meaningfully 'dosed for women's bodies' is a marketing claim rather than a documented protocol — ask what it means in practice.
Is Gala's medication FDA-approved?
Partly. Its brand-name Ozempic is FDA-approved. Its compounded GLP-1 and microdosed GLP-1/GIP products are not — they have not been evaluated for safety, efficacy or quality and are not therapeutically equivalent to Ozempic, Wegovy, Mounjaro or Zepbound beyond the shared active ingredient. Microdosing is also not an FDA-approved dosing strategy.
Important Notes & Warnings
- This review is informational only and is not medical advice. Consult a licensed clinician before starting or changing treatment.
- Gala's published weight-loss percentages are MODELLED from the branded molecule's trial data, not measured in its own patients — the company discloses this in a footnote.
- The claim that GLP-1 plus provider care produces −20% versus −15% for GLP-1 alone is published without support.
- Gala's chart attributes 'twelve-week clinical data' to STEP-1; that trial ran 68 weeks.
- Compounded GLP-1 and microdosed GLP-1/GIP products are NOT FDA-approved and are not therapeutically equivalent to branded products beyond the shared active ingredient.
- Microdosing is not an FDA-approved dosing strategy and lacks the outcome evidence behind standard dosing.
- Brand-name Ozempic at $1,299/month is approximately full cash list — use insurance elsewhere if you have coverage.
- GLP-1 medicines are contraindicated in pregnancy and in people with a personal or family history of medullary thyroid carcinoma or MEN2. If you are pregnant, planning pregnancy or breastfeeding, discuss this with a clinician first.
- Hormone therapy carries its own considerations including cardiovascular and breast health — discuss your history before starting.
Sources
- Gala Health weight-loss, hormone and treatment pages, galaglp1.com (accessed 7 August 2026)
- STEP 1 trial (semaglutide 2.4mg, 68 weeks), for context on the data Gala's chart attributes to STEP-1
Medical Disclaimer
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Talk to a healthcare provider before starting, changing, or stopping any treatment, and call emergency services for urgent symptoms.
Facts in this review were compiled from the provider's own public website and public search results as of August 7, 2026. Prices, medication availability, pharmacy partners, and policies change frequently and vary by state — verify everything directly with the provider before purchasing.
This page contains affiliate links. We may earn a commission from qualifying purchases at no additional cost to you.